HK1201531A1 - 雜環化合物和其用法 - Google Patents

雜環化合物和其用法

Info

Publication number
HK1201531A1
HK1201531A1 HK15102121.1A HK15102121A HK1201531A1 HK 1201531 A1 HK1201531 A1 HK 1201531A1 HK 15102121 A HK15102121 A HK 15102121A HK 1201531 A1 HK1201531 A1 HK 1201531A1
Authority
HK
Hong Kong
Prior art keywords
methods
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
HK15102121.1A
Other languages
English (en)
Inventor
Thomas David Mccarthy
Alan Naylor
Original Assignee
Spinifex Pharm Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012900285A external-priority patent/AU2012900285A0/en
Application filed by Spinifex Pharm Pty Ltd filed Critical Spinifex Pharm Pty Ltd
Publication of HK1201531A1 publication Critical patent/HK1201531A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
HK15102121.1A 2012-01-25 2015-03-03 雜環化合物和其用法 HK1201531A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2012900285A AU2012900285A0 (en) 2012-01-25 Methods of treatment or prophylaxis
PCT/AU2013/000062 WO2013110135A1 (en) 2012-01-25 2013-01-25 Heterocyclic compounds and methods for their use

Publications (1)

Publication Number Publication Date
HK1201531A1 true HK1201531A1 (zh) 2015-09-04

Family

ID=48872833

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102121.1A HK1201531A1 (zh) 2012-01-25 2015-03-03 雜環化合物和其用法

Country Status (13)

Country Link
US (1) US9624234B2 (zh)
EP (1) EP2807171B1 (zh)
JP (1) JP6073926B2 (zh)
CN (1) CN104470930B (zh)
AU (1) AU2013202978B2 (zh)
CA (1) CA2861233C (zh)
ES (1) ES2830023T3 (zh)
HK (1) HK1201531A1 (zh)
NZ (1) NZ627558A (zh)
PL (1) PL2807171T3 (zh)
PT (1) PT2807171T (zh)
WO (1) WO2013110135A1 (zh)
ZA (1) ZA201405257B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107011229B (zh) 2012-01-06 2019-11-05 诺华股份有限公司 杂环化合物和它们的使用方法
ES2798289T3 (es) 2012-01-25 2020-12-10 Novartis Ag Compuestos heterocíclicos y métodos para su uso
WO2015003223A1 (en) 2013-07-08 2015-01-15 Spinifex Pharmaceuticals Pty Ltd Heterocyclic compounds and methods of their use
JP6667551B2 (ja) * 2015-01-13 2020-03-18 ノバルティス アーゲー アンジオテンシンｉｉ２型拮抗薬としてのピロリジン誘導体
WO2016142867A1 (en) 2015-03-12 2016-09-15 Novartis Ag Heterocyclic compounds and methods for their use
CN105021735B (zh) * 2015-07-21 2017-09-19 中国科学院西北高原生物研究所 白刺种子或其提取物中ss和rsMTCA的检测方法
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
WO2018195020A1 (en) 2017-04-18 2018-10-25 Breakthrough Technologies, LLC Sulfur production
WO2019040105A2 (en) * 2017-08-21 2019-02-28 Acadia Pharmaceuticals Inc. COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES
US11453690B2 (en) * 2018-03-23 2022-09-27 Beijing Tide Pharmaceutical Co., Ltd. Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
CN112313222B (zh) * 2018-06-19 2024-01-26 浙江海正药业股份有限公司 四氢异喹啉类衍生物、其制备方法及其用途
CN110128393B (zh) * 2019-06-21 2022-09-30 华侨大学 一种取代异香豆素衍生物的制备方法
CN113880825A (zh) 2020-07-01 2022-01-04 浙江海正药业股份有限公司 四氢异喹啉类衍生物的盐、其制备方法及其医药应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0018104B1 (en) * 1979-03-26 1983-05-25 Takeda Chemical Industries, Ltd. Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension
FR2487829A2 (fr) 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2470767A1 (fr) 1979-12-07 1981-06-12 Science Union & Cie Nouveaux iminoacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzymes
DE3134933A1 (de) 1981-09-03 1983-03-31 Hoechst Ag, 6230 Frankfurt "harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente sowie deren verwendung"
DE3302126A1 (de) 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung
JPS6216466A (ja) 1985-07-16 1987-01-24 Iwaki Seiyaku Kk テトラヒドロピリジン誘導体
US5612360A (en) 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
US5236934A (en) * 1992-08-26 1993-08-17 E. I. Du Pont De Nemours And Company 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
US5610165A (en) 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
JPH0892207A (ja) 1994-07-26 1996-04-09 Sankyo Co Ltd ピロリジン誘導体
BE1012622A3 (fr) 1999-04-21 2001-01-09 Solvay Procede pour la separation d'enantiomeres et reactif enantiopur.
JP4827821B2 (ja) 2004-05-26 2011-11-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 シンナミド化合物
KR101128065B1 (ko) 2004-05-26 2012-04-12 에자이 알앤드디 매니지먼트 가부시키가이샤 신나미드 화합물
US7612089B2 (en) * 2004-11-19 2009-11-03 Portola Pharmaceuticals, Inc. Tetrahydroisoquinolines as factor Xa inhibitors
EP2650011A1 (en) 2004-12-24 2013-10-16 Spinifex Pharmaceuticals Pty Ltd Method of treatment or prophylaxis
US8551950B2 (en) 2006-03-20 2013-10-08 Spinifex Pharmaceuticals Pty Ltd Method of treatment or prophylaxis of inflammatory pain
AU2011207104C1 (en) * 2010-01-19 2015-10-08 Novartis Ag Methods and compositions for improved nerve conduction velocity

Also Published As

Publication number Publication date
WO2013110135A1 (en) 2013-08-01
EP2807171A1 (en) 2014-12-03
CN104470930B (zh) 2017-02-22
EP2807171B1 (en) 2020-08-12
EP2807171A4 (en) 2015-10-21
JP6073926B2 (ja) 2017-02-01
US9624234B2 (en) 2017-04-18
US20150218180A1 (en) 2015-08-06
ES2830023T3 (es) 2021-06-02
NZ627558A (en) 2016-07-29
JP2015504901A (ja) 2015-02-16
CA2861233A1 (en) 2013-08-01
CN104470930A (zh) 2015-03-25
PT2807171T (pt) 2020-11-03
AU2013202978B2 (en) 2016-05-19
ZA201405257B (en) 2016-10-26
CA2861233C (en) 2021-05-04
PL2807171T3 (pl) 2021-01-25

Similar Documents

Publication Publication Date Title
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
HK1207069A1 (zh) 雜環化合物及其應用
HK1199725A1 (zh) 雜環化合物及其用途
HK1198475A1 (zh) 雜環化合物及其應用
HK1198443A1 (zh) 雜環化合物及其用途
HK1208439A1 (zh) -氮雜吲唑化合物及其使用方法
HK1193561A1 (zh) 雜環化合物和其用途
HK1201521A1 (zh) 雜環化合物及其使用方法
HK1201531A1 (zh) 雜環化合物和其用法
HK1201533A1 (zh) 雜化化合物及其應用方法
EP2821401A4 (en) HETEROCYCLIC COMPOUND AND USE THEREOF
EP2938341A4 (en) Heterocyclic compounds and methods for the use thereof
AP2015008591A0 (en) Heterocyclic compounds
EP2850077A4 (en) BIOZIDE COMPOUNDS AND METHOD FOR USE THEREOF
EP2886546A4 (en) Heterocyclic compound and use thereof
AP3611A (en) Heterocyclic compounds and their uses
HK1206350A1 (zh) -咪唑- -胺化合物及其作為 抑制劑的用途
HK1201270A1 (zh) 四唑- -基-和三唑- -基-芳基化合物及其作為除草劑的用途
EP2813508A4 (en) HETEROCYCLIC COMPOUND AND APPLICATION THEREOF
EP2782571A4 (en) HETEROCYCLIC COMPOUNDS AND USES THEREOF
GB201213726D0 (en) Novel compounds and their use